Quarterly report · Q3
4021.TEDINET S100SRRZ
Period2023-04-01 → 2023-12-31
Filed2024-02-13
StandardJapan GAAP
ConsolidatedYes
Data checks14 of 14 passed
Key figures · 46
| Metric | Value | Period | Scope | Source row |
|---|---|---|---|---|
| Revenue | ¥155.3bn | 2023-04-01 → 2023-12-31 | Cons. | Net sales |
| Revenue | ¥228.1bn | 2022-04-01 → 2023-03-31 | Cons. | Net sales (5-year summary) |
| Revenue | ¥159.2bn | 2022-04-01 → 2022-12-31 | Cons. | Net sales |
| Operating income | ¥33.4bn | 2023-04-01 → 2023-12-31 | Cons. | Operating income |
| Operating income | ¥38.8bn | 2022-04-01 → 2022-12-31 | Cons. | Operating income |
| Ordinary income | ¥35.0bn | 2023-04-01 → 2023-12-31 | Cons. | Ordinary income |
| Ordinary income | ¥55.8bn | 2022-04-01 → 2023-03-31 | Cons. | Ordinary income loss (5-year summary) |
| Ordinary income | ¥41.3bn | 2022-04-01 → 2022-12-31 | Cons. | Ordinary income |
| Profit before tax | ¥35.7bn | 2023-04-01 → 2023-12-31 | Cons. | Income before income taxes |
| Profit before tax | ¥41.3bn | 2022-04-01 → 2022-12-31 | Cons. | Income before income taxes |
| Net income (owners) | ¥26.0bn | 2023-04-01 → 2023-12-31 | Cons. | Profit loss attributable to owners of parent |
| Net income (owners) | ¥41.1bn | 2022-04-01 → 2023-03-31 | Cons. | Profit loss attributable to owners of parent (5-year summary) |
| Net income (owners) | ¥30.8bn | 2022-04-01 → 2022-12-31 | Cons. | Profit loss attributable to owners of parent |
| Net income | ¥26.1bn | 2023-04-01 → 2023-12-31 | Cons. | Profit loss |
| Net income | ¥31.0bn | 2022-04-01 → 2022-12-31 | Cons. | Profit loss |
| Total assets | ¥309.7bn | at 2023-12-31 | Cons. | Assets |
| Total assets | ¥298.7bn | at 2023-03-31 | Cons. | Assets |
| Total assets | ¥276.6bn | at 2022-12-31 | Cons. | Total assets (5-year summary) |
| Total liabilities | ¥88.4bn | at 2023-12-31 | Cons. | Liabilities |
| Total liabilities | ¥77.2bn | at 2023-03-31 | Cons. | Liabilities |
| Net assets / equity | ¥221.4bn | at 2023-12-31 | Cons. | Net assets |
| Net assets / equity | ¥221.5bn | at 2023-03-31 | Cons. | Net assets |
| Net assets / equity | ¥216.2bn | at 2022-12-31 | Cons. | Net assets (5-year summary) |
| Cash and deposits | ¥25.7bn | at 2023-12-31 | Cons. | Cash and deposits |
| Cash and deposits | ¥29.6bn | at 2023-03-31 | Cons. | Cash and deposits |
| Cash & equivalents | ¥25.7bn | at 2023-12-31 | Cons. | Cash and cash equivalents |
| Cash & equivalents | ¥29.6bn | at 2023-03-31 | Cons. | Cash and cash equivalents |
| Cash & equivalents | ¥25.9bn | at 2022-12-31 | Cons. | Cash and cash equivalents |
| Cash & equivalents | ¥34.7bn | at 2022-03-31d | Cons. | Cash and cash equivalents |
| Operating cash flow | ¥33.7bn | 2023-04-01 → 2023-12-31 | Cons. | Net cash provided by used in operating activities |
| Operating cash flow | ¥35.2bn | 2022-04-01 → 2023-03-31 | Cons. | Net cash provided by used in operating activities (5-year summary) |
| Operating cash flow | ¥37.8bn | 2022-04-01 → 2022-12-31 | Cons. | Net cash provided by used in operating activities |
| Investing cash flow | −¥11.9bn | 2023-04-01 → 2023-12-31 | Cons. | Net cash provided by used in investment activities |
| Investing cash flow | −¥19.6bn | 2022-04-01 → 2023-03-31 | Cons. | Net cash provided by used in investing activities (5-year summary) |
| Investing cash flow | −¥13.5bn | 2022-04-01 → 2022-12-31 | Cons. | Net cash provided by used in investment activities |
| Financing cash flow | −¥25.9bn | 2023-04-01 → 2023-12-31 | Cons. | Net cash provided by used in financing activities |
| Financing cash flow | −¥25.0bn | 2022-04-01 → 2023-03-31 | Cons. | Net cash provided by used in financing activities (5-year summary) |
| Financing cash flow | −¥37.5bn | 2022-04-01 → 2022-12-31 | Cons. | Net cash provided by used in financing activities |
| EPS (basic) | ¥186.02 | 2023-04-01 → 2023-12-31 | Cons. | Basic earnings loss per share (5-year summary) |
| EPS (basic) | ¥46.44 | 2023-10-01 → 2023-12-31d | Cons. | Basic earnings loss per share (5-year summary) |
| EPS (basic) | ¥291.36 | 2022-04-01 → 2023-03-31 | Cons. | Basic earnings loss per share (5-year summary) |
| EPS (basic) | ¥217.99 | 2022-04-01 → 2022-12-31 | Cons. | Basic earnings loss per share (5-year summary) |
| EPS (basic) | ¥50.21 | 2022-10-01 → 2022-12-31d | Cons. | Basic earnings loss per share (5-year summary) |
| Equity ratio | 70.4% | at 2023-12-31 | Cons. | Equity to asset ratio (5-year summary) |
| Equity ratio | 73.1% | at 2023-03-31 | Cons. | Equity to asset ratio (5-year summary) |
| Equity ratio | 77.1% | at 2022-12-31 | Cons. | Equity to asset ratio (5-year summary) |
Periods use the dates stated in the filing. d = earlier-year period dated by calendar; v = that date confirmed by the company's own earlier filing.
Segments · 64
| Segment | Item | Period | Value |
|---|---|---|---|
| Otherother segments | revenue | 2023-04-01 → 2023-12-31 | ¥18.3bn |
| Otherother segments | revenue external | 2023-04-01 → 2023-12-31 | ¥7.3bn |
| Otherother segments | revenue intersegment | 2023-04-01 → 2023-12-31 | ¥11.0bn |
| Otherother segments | segment profit | 2023-04-01 → 2023-12-31 | −¥43m |
| Reconciling Itemsreconciling | revenue | 2023-04-01 → 2023-12-31 | −¥82.8bn |
| Reconciling Itemsreconciling | revenue external | 2023-04-01 → 2023-12-31 | −¥20.5bn |
| Reconciling Itemsreconciling | revenue intersegment | 2023-04-01 → 2023-12-31 | −¥62.3bn |
| Reconciling Itemsreconciling | segment profit | 2023-04-01 → 2023-12-31 | −¥3.8bn |
| jpcrp040300-q3r_E00759-000Agricultural Chemical Productsreportable segment | revenue | 2023-04-01 → 2023-12-31 | ¥48.5bn |
| jpcrp040300-q3r_E00759-000Agricultural Chemical Productsreportable segment | revenue external | 2023-04-01 → 2023-12-31 | ¥38.1bn |
| jpcrp040300-q3r_E00759-000Agricultural Chemical Productsreportable segment | revenue intersegment | 2023-04-01 → 2023-12-31 | ¥10.3bn |
| jpcrp040300-q3r_E00759-000Agricultural Chemical Productsreportable segment | segment profit | 2023-04-01 → 2023-12-31 | ¥14.5bn |
| jpcrp040300-q3r_E00759-000Chemical Productsreportable segment | revenue | 2023-04-01 → 2023-12-31 | ¥27.5bn |
| jpcrp040300-q3r_E00759-000Chemical Productsreportable segment | revenue external | 2023-04-01 → 2023-12-31 | ¥18.3bn |
| jpcrp040300-q3r_E00759-000Chemical Productsreportable segment | revenue intersegment | 2023-04-01 → 2023-12-31 | ¥9.3bn |
| jpcrp040300-q3r_E00759-000Chemical Productsreportable segment | segment profit | 2023-04-01 → 2023-12-31 | ¥283m |
| jpcrp040300-q3r_E00759-000Functional Materialsreportable segment | revenue | 2023-04-01 → 2023-12-31 | ¥61.9bn |
| jpcrp040300-q3r_E00759-000Functional Materialsreportable segment | revenue external | 2023-04-01 → 2023-12-31 | ¥49.6bn |
| jpcrp040300-q3r_E00759-000Functional Materialsreportable segment | revenue intersegment | 2023-04-01 → 2023-12-31 | ¥12.3bn |
| jpcrp040300-q3r_E00759-000Functional Materialsreportable segment | segment profit | 2023-04-01 → 2023-12-31 | ¥17.4bn |
| jpcrp040300-q3r_E00759-000Medicinesreportable segment | revenue | 2023-04-01 → 2023-12-31 | ¥4.8bn |
| jpcrp040300-q3r_E00759-000Medicinesreportable segment | revenue external | 2023-04-01 → 2023-12-31 | ¥4.8bn |
| jpcrp040300-q3r_E00759-000Medicinesreportable segment | revenue intersegment | 2023-04-01 → 2023-12-31 | ¥57m |
| jpcrp040300-q3r_E00759-000Medicinesreportable segment | segment profit | 2023-04-01 → 2023-12-31 | ¥2.3bn |
| jpcrp040300-q3r_E00759-000Wholesalereportable segment | revenue | 2023-04-01 → 2023-12-31 | ¥77.1bn |
| jpcrp040300-q3r_E00759-000Wholesalereportable segment | revenue external | 2023-04-01 → 2023-12-31 | ¥57.7bn |
| jpcrp040300-q3r_E00759-000Wholesalereportable segment | revenue intersegment | 2023-04-01 → 2023-12-31 | ¥19.4bn |
| jpcrp040300-q3r_E00759-000Wholesalereportable segment | segment profit | 2023-04-01 → 2023-12-31 | ¥2.8bn |
| Total Of Reportable Segments And Otherssegment total | revenue | 2023-04-01 → 2023-12-31 | ¥238.2bn |
| Total Of Reportable Segments And Otherssegment total | revenue external | 2023-04-01 → 2023-12-31 | ¥175.9bn |
| Total Of Reportable Segments And Otherssegment total | revenue intersegment | 2023-04-01 → 2023-12-31 | ¥62.3bn |
| Total Of Reportable Segments And Otherssegment total | segment profit | 2023-04-01 → 2023-12-31 | ¥37.3bn |
| Otherother segments | revenue | 2022-04-01 → 2022-12-31 | ¥19.1bn |
| Otherother segments | revenue external | 2022-04-01 → 2022-12-31 | ¥8.2bn |
| Otherother segments | revenue intersegment | 2022-04-01 → 2022-12-31 | ¥11.0bn |
| Otherother segments | segment profit | 2022-04-01 → 2022-12-31 | ¥343m |
| Reconciling Itemsreconciling | revenue | 2022-04-01 → 2022-12-31 | −¥80.6bn |
| Reconciling Itemsreconciling | revenue external | 2022-04-01 → 2022-12-31 | −¥22.3bn |
| Reconciling Itemsreconciling | revenue intersegment | 2022-04-01 → 2022-12-31 | −¥58.3bn |
| Reconciling Itemsreconciling | segment profit | 2022-04-01 → 2022-12-31 | −¥4.1bn |
| jpcrp040300-q3r_E00759-000Agricultural Chemical Productsreportable segment | revenue | 2022-04-01 → 2022-12-31 | ¥48.8bn |
| jpcrp040300-q3r_E00759-000Agricultural Chemical Productsreportable segment | revenue external | 2022-04-01 → 2022-12-31 | ¥40.4bn |
| jpcrp040300-q3r_E00759-000Agricultural Chemical Productsreportable segment | revenue intersegment | 2022-04-01 → 2022-12-31 | ¥8.4bn |
| jpcrp040300-q3r_E00759-000Agricultural Chemical Productsreportable segment | segment profit | 2022-04-01 → 2022-12-31 | ¥15.2bn |
| jpcrp040300-q3r_E00759-000Chemical Productsreportable segment | revenue | 2022-04-01 → 2022-12-31 | ¥29.9bn |
| jpcrp040300-q3r_E00759-000Chemical Productsreportable segment | revenue external | 2022-04-01 → 2022-12-31 | ¥20.5bn |
| jpcrp040300-q3r_E00759-000Chemical Productsreportable segment | revenue intersegment | 2022-04-01 → 2022-12-31 | ¥9.4bn |
| jpcrp040300-q3r_E00759-000Chemical Productsreportable segment | segment profit | 2022-04-01 → 2022-12-31 | ¥1.5bn |
| jpcrp040300-q3r_E00759-000Functional Materialsreportable segment | revenue | 2022-04-01 → 2022-12-31 | ¥62.6bn |
| jpcrp040300-q3r_E00759-000Functional Materialsreportable segment | revenue external | 2022-04-01 → 2022-12-31 | ¥50.6bn |
| jpcrp040300-q3r_E00759-000Functional Materialsreportable segment | revenue intersegment | 2022-04-01 → 2022-12-31 | ¥12.0bn |
| jpcrp040300-q3r_E00759-000Functional Materialsreportable segment | segment profit | 2022-04-01 → 2022-12-31 | ¥20.8bn |
| jpcrp040300-q3r_E00759-000Medicinesreportable segment | revenue | 2022-04-01 → 2022-12-31 | ¥4.8bn |
| jpcrp040300-q3r_E00759-000Medicinesreportable segment | revenue external | 2022-04-01 → 2022-12-31 | ¥4.8bn |
| jpcrp040300-q3r_E00759-000Medicinesreportable segment | revenue intersegment | 2022-04-01 → 2022-12-31 | ¥10m |
| jpcrp040300-q3r_E00759-000Medicinesreportable segment | segment profit | 2022-04-01 → 2022-12-31 | ¥2.1bn |
| jpcrp040300-q3r_E00759-000Wholesalereportable segment | revenue | 2022-04-01 → 2022-12-31 | ¥74.7bn |
| jpcrp040300-q3r_E00759-000Wholesalereportable segment | revenue external | 2022-04-01 → 2022-12-31 | ¥57.1bn |
| jpcrp040300-q3r_E00759-000Wholesalereportable segment | revenue intersegment | 2022-04-01 → 2022-12-31 | ¥17.6bn |
| jpcrp040300-q3r_E00759-000Wholesalereportable segment | segment profit | 2022-04-01 → 2022-12-31 | ¥2.9bn |
| Total Of Reportable Segments And Otherssegment total | revenue | 2022-04-01 → 2022-12-31 | ¥239.8bn |
| Total Of Reportable Segments And Otherssegment total | revenue external | 2022-04-01 → 2022-12-31 | ¥181.5bn |
| Total Of Reportable Segments And Otherssegment total | revenue intersegment | 2022-04-01 → 2022-12-31 | ¥58.3bn |
| Total Of Reportable Segments And Otherssegment total | segment profit | 2022-04-01 → 2022-12-31 | ¥42.9bn |
Segment names come from EDINET member IDs; not yet mapped to a common taxonomy.
All source rows · 516
| Item | Context | Value | Unit |
|---|---|---|---|
| Notes regarding guarantee obligations (text) | CurrentQuarterInstant | Text · Plus | |
| Notes regarding promissory notes due on balance sheet date (text) | CurrentQuarterInstant | Text · Plus | |
| Creditors notes regarding overdraft contracts and or loan commitments (text) | CurrentQuarterInstant | Text · Plus | |
| Notes quarterly consolidated statement of income (text) | CurrentYTDDuration | Text · Plus | |
| Reconciliation of ending balance of cash and cash equivalents with account balances per balance sheet (text) | CurrentYTDDuration | Text · Plus | |
| Notes regarding dividend (text) | Prior1YTDDuration | Text · Plus | |
| Notes when there is significant changes in amounts of equity (text) | Prior1YTDDuration | Text · Plus | |
| Notes regarding dividend (text) | CurrentYTDDuration | Text · Plus | |
| Notes when there is significant changes in amounts of equity (text) | CurrentYTDDuration | Text · Plus | |
| Notes segment information etc quarterly consolidated financial statements (text) | CurrentYTDDuration | Text · Plus | |
| Footnotes regarding segment information table (text) | Prior1YTDDuration | Text · Plus | |
| Footnotes regarding segment information table (text) | CurrentYTDDuration | Text · Plus | |
| Notes revenue recognition quarterly consolidated financial statements (text) | CurrentYTDDuration | Text · Plus | |
| Notes per share information quarterly consolidated financial statements (text) | CurrentYTDDuration | Text · Plus | |
| Other information consolidated financial statements etc (text) | CurrentYTDDuration | Text · Plus | |
| Information about company which provides guarantee to reporting company (text) | FilingDateInstant | Text · Plus |
Every row of the EDINET CSV. Item names are the XBRL element names; filed text is kept in its original Japanese. Filed text is available on Plus and Pro.
Data checks · 14 of 14 passed
| balance sheet identity | pass rounding |
| balance sheet identity | pass rounding |
| dei present | pass |
| period resolution | pass |
| statement vs summary · net assets | pass |
| statement vs summary · net assets | pass |
| statement vs summary · net income attributable to parent | pass |
| statement vs summary · net income attributable to parent | pass |
| statement vs summary · operating cash flow | pass |
| statement vs summary · operating cash flow | pass |
| statement vs summary · revenue | pass |
| statement vs summary · revenue | pass |
| statement vs summary · total assets | pass |
| statement vs summary · total assets | pass |